 Shares of Becton Dickinson Co. rallied 2.3 in premarket trading Tuesday, after the medical technology company provided an upbeat outlook for its first quarter. For the quarter ended Dec. 31, the company expects to report revenue of 5.3 billion, up 26 from a year ago and above the FactSet consensus of 4.7 billion. 